This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsApellis PharmaceuticalsApellis Pharmaceuticals Funding Rounds, Valuation & Investors
Biopharmaceutical company creating therapies for debilitating diseases501-1000 Employees
Apellis Pharmaceuticals Funding
$0
55 rounds
Apellis Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on February 12, 2016.
Funding Rounds
D
$47100000C
$33000000U
$6000000U
$3000000U
$1700000Investors of Apellis Pharmaceuticals
Early stage investor focused on Kentucky, US
Morningside Private Investors
Epidarex Capital
Morningside Group
Rounds
D
VenBio
Rounds
D
Aju IB Investment
Rounds
D
C
Hillhouse Capital
Rounds
D
Acquisitions of Apellis Pharmaceuticals
Potentia Pharmaceuticals
Exit